1.Clinical analysis of 19 cases of ectopic appendicitis with laparoscopic exploration and appendectomy
Tabusi AHETIBIEKE ; Jun ZHOU ; Jianhui LI ; Aman NUERBAOLATI ; Longlong AI ; Yujiang ZHANG ; Tongxin ZHANG
International Journal of Surgery 2015;42(7):460-462
Objective To explore the clinical manifestations,diagnosed main points,laparoscopic trestment strategy of ectopic appendicitis.Methods The 19 clinical data of ectopic appendicitis,from April 2011 to April 2015 in our hosipital,were retrospective analysised,and we sum up the clinical manifestation,diagnosis and treatment,laparoscopic exploration indications and the technique of laparoscopic appendectomy.Laparoscopy exploration and laparoscopic appendectomy were made on all patients under general anesthesia by tracheal cannula.Results Of 19 patients,16 cases by ultrasonic examination get correct diagnosis before operation,of which the ultrasound diagnosis rate is 92.63%,3 limitations of acute peritonitis patients were preoperative misdiagno~s,they were the right kidney stones,acute cholecystitis and the right side of the annex inflammation;there were 2 patients converted to open operation,and the transfer rate is 10.53%.The blood loss of the operation is about 5-20 mL.They were ambulant after 9 hours,in full flow diet after 12 hours,and the average hospitalization time is 4 days.One patient,no other long-term complications were found postoperatively follow-up of 12 to 18 months,were poke holes in infection,and the complications of laparoscopic surgery is 5.27%.Conclusions Ectopic acute appendicitis has no specific clinical manifestation,and is easy to misdiagnosis.In the auxiliary examination,ultrasound is the first choice for the diagnosis of ectopic appendictis.Laparoscopy exploration and laparoscopic appendectomy are the ideal treatments of emergency treatment of ectopic appendicitis,and are worth of clinic application.
2.Effect of body mass index on postoperative outcomes in patients with gastric cancer.
Li ZHANG ; Aman XU ; Wenxiu HAN ; Zhijian WEI ; Maoming XIONG ; Wenqi YANG ; Kongwang HU
Chinese Journal of Gastrointestinal Surgery 2016;19(3):296-299
OBJECTIVETo explore the effect of body mass index (BMI) on postoperative short-term prognosis and survival rate of gastric cancer patients.
METHODSClinical and follow-up date of 153 gastric cancer cases undergoing radical operation in our hospital from January to June 2010 were retrospectively analyzed. According to BMI, patients were divided into low group (BMI<18.5, 23 cases), normal group (18.5≤BMI<25.0, 95 cases) and high group (BMI≥25.0, 35 cases). Clinicopathological features and outcomes were compared the among three groups.
RESULTSAmong three groups, the differences in operation time, intraoperative blood loss, number of lymph node retrieved, postoperative hospital stay, lymph node metastasis rate, tumor staging and postoperative complication morbidity were not statistically significant (all P>0.05). Preoperative hemoglobin in the low group was significantly lower as compared to normal and high groups [(106.1±13.8) g/L vs. 113.5±5.2) g/L and (123.5±8.7) g/L, F=3.265, P=0.041], and so was the preoperative albumin [(38.7±2.5) g/L vs. (41.3±0.8) g/L and (43.5±1.4) g/L, F=8.516, P=0.000]. The ratio of gastric cardiac cancer in the low group was significantly lower as compared to the normal and high groups[34.8%(8/23) vs. 68.4%(65/95) and 62.9%(22/35), χ(2)=8.913, P=0.012]. Five-year survival rate of the low, normal and high groups were 43.5%, 50.5% and 65.7% respectively(P=0.189). Subgroup analysis showed that the 5-year survival rate of patients with gastric cardiac cancer in the low group was significantly lower as compared to those in the high group (25.0% vs. 84.6%, P=0.004).
CONCLUSIONSBMI dose not generally play a role in short-term outcomes and long-term survival of the gastric cancer patients. Nutritional improvement and body weight maintenance may be beneficial to low BMI patients, especially those with gastric cardiac cancer.
Blood Loss, Surgical ; Body Mass Index ; Gastrectomy ; Humans ; Length of Stay ; Lymph Nodes ; Lymphatic Metastasis ; Neoplasm Staging ; Operative Time ; Postoperative Complications ; Postoperative Period ; Retrospective Studies ; Stomach Neoplasms ; surgery ; Survival Rate ; Treatment Outcome
3.Effects of mobile phone APP in self-management of asthma patients: a Meta-analysis
Aman LI ; Shuo CHEN ; Qian XIAO ; Yanling WANG
Chinese Journal of Modern Nursing 2023;29(2):237-241
Objective:To systematically evaluate the effect of mobile phone APP in self-management of asthma patients through comprehensive and systematic retrieval of relevant research at home and abroad, so as to provide evidence-based basis for asthma health management.Methods:We retrieved PubMed, Web of Science, Embase, Medline, CINAHL, Cochrane Library, China Biomedical Literature Service System, China National Knowledge Infrastructure (CNKI) , VIP, WanFang Data, and manually searched unpublished literature to collect the randomized controlled trial (RCT) related to the self-management of asthma patients using mobile phone APP published from January 1, 2000 to January 1, 2022. Two researchers independently screened, evaluated literature and extracted data according to inclusion and exclusion criteria. RevMan 5.3 was used to analyze the data.Results:A total of 10 articles were included, including 6 in English and 4 in Chinese, and 990 patients were included, including 494 in the test group and 496 in the control group. Meta-analysis showed that there were statistically significant differences between the two groups in the number of emergency visits and forced expiratory volume in one second ( P<0.05) . Conclusions:In the self-management of asthma patients, the use of mobile phone APP can improve the lung function of asthma patients and the consumption of medical resources to a certain extent compared with conventional intervention, but the role of other aspects such as asthma control and quality of life still needs to be further verified.
4.Challenge of New Norms: Obesity amid COVID-19 Pandemic
Ubaidah Naim Taraq Naem Zia ; Lee Ii Li ; Siti Syariah Mamat
Malaysian Journal of Medicine and Health Sciences 2022;18(No.5):208-214
COVID-19 pandemic aggravated the global public health system, which is already overwhelmed by the increasing
statistics of comorbidities and burden due to obesity. The number of individuals with obesity and obesity-associated
diseases are rising in many regions that could attribute to the growing obesogenic environment and the lockdown
implemented to curb COVID-19. This review focuses on the aspects of the obesity epidemic, chronic inflammatory
effects of obesity, positive outcomes of obesity interventions and the worsening effects observed in obese COVID-19
patients. The chronic inflammatory effects of obesity are apparent by the increase of pro-inflammatory signals by
immune cells in the adipose tissue and reactive species populations. The reduction of antioxidants exacerbates the
effects of oxidative stress on genomic and tissue levels. The public must be made aware of the importance of practising a healthier lifestyle, even more now as we are fighting the COVID-19 pandemic.
5.Distribution and characteristics of hepatitis B virus genotypes in Uighur patients with chronic hepatitis B in Xinjiang province of China.
Xiao-bo LU ; Xiao-lan WANG ; Guo-hong DENG ; Xue-mei KUANG ; Gu-li AMAN ; Yue-xin ZHANG ; Jian-long ZHANG ; Yu-ming WANG
Chinese Journal of Hepatology 2007;15(4):241-244
OBJECTIVETo study genotype distribution and the characteristics of hepatitis B virus (HBV) in Uighur patients with chronic hepatitis B (CHB) in Xinjiang, China.
METHODSType specific primers and PCR were used to detect the HBV genotypes of 127 Uighur CHB patients in Xinjiang. Genotyping results were confirmed by PCR product sequencing.
RESULTSAmong the 127 patients, the proportions of genotype D, B, C and B/D, C/D, B/C/D were 39.4% (50/127), 22.0% (28/127), 16.5% (21/127) and 9.4% (12/127), 8.7% (11/127) and 3.9% (5/127), respectively. The distribution of the HBV genotypes showed no significant differences between male and female patients (x2 = 8.058, P > 0.05), between HBeAg positive and negative patients (x2 = 6.033, P > 0.05), and between patients of different ages (x2 = 3.137, P > 0.05).
CONCLUSIONGenotype D HBV is predominant in Uighur patients with chronic hepatitis B in Xinjiang. The distribution of various HBV genotypes shows no significant differences between these Uighur patients with different HBeAg positivity, sex and age.
Adolescent ; Adult ; Child ; Child, Preschool ; China ; epidemiology ; DNA, Viral ; Female ; Genome, Viral ; Genotype ; Hepatitis B virus ; genetics ; Hepatitis B, Chronic ; epidemiology ; virology ; Humans ; Male ; Middle Aged ; Young Adult
6.Effect of edaravone in diabetes mellitus-induced nephropathy in rats.
Rajavel VARATHARAJAN ; Li Xin LIM ; Kelly TAN ; Chai Sze TAY ; Yi Leng TEOH ; Shaikh Sohrab AKHTAR ; Mani RUPESHKUMAR ; Ivy CHUNG ; Nor Azizan ABDULLAH ; Urmila BANIK ; Sokkalingam A DHANARAJ ; Pitchai BALAKUMAR
The Korean Journal of Physiology and Pharmacology 2016;20(4):333-340
Edaravone, a synthetic-free radical scavenger, has been reported to reduce ischemia-reperfusion-induced renal injury by improving tubular cell function, and lowering serum creatinine and renal vascular resistance. The present study investigated the effect of edaravone in diabetes mellitus-induced nephropathy in rats. A single administration of streptozotocin (STZ, 55 mg/kg, i.p.) was employed to induce diabetes mellitus in rats. The STZ-administered diabetic rats were allowed for 10 weeks to develop nephropathy. Mean body weight, lipid alteration, renal functional and histopathology were analysed. Diabetic rats developed nephropathy as evidenced by a significant increase in serum creatinine and urea, and marked renal histopathological abnormalities like glomerulosclerosis and tubular cell degeneration. The kidney weight to body weight ratio was increased. Moreover, diabetic rats showed lipid alteration as evidenced by a signifi cant increase in serum triglycerides and decrease in serum high-density lipoproteins. Edaravone (10 mg/kg, i.p., last 4-weeks) treatment markedly prevented the development of nephropathy in diabetic rats by reducing serum creatinine and urea and preventing renal structural abnormalities. In addition, its treatment, without significantly altering the elevated glucose level in diabetic rats, prevented diabetes mellitus-induced lipid alteration by reducing serum triglycerides and increasing serum high-density lipoproteins. Interestingly, the renoprotective effect of edaravone was comparable to that of lisinopril (5 mg/kg, p.o, 4 weeks, standard drug). Edaravone prevented renal structural and functional abnormalities and lipid alteration associated with experimental diabetes mellitus. Edaravone has a potential to prevent nephropathy without showing an anti-diabetic action, implicating its direct renoprotection in diabetic rats.
Animals
;
Body Weight
;
Creatinine
;
Diabetes Mellitus
;
Diabetes Mellitus, Experimental
;
Diabetic Nephropathies
;
Glucose
;
Kidney
;
Lipoproteins, HDL
;
Lisinopril
;
Rats*
;
Streptozocin
;
Triglycerides
;
Urea
;
Vascular Resistance